VoICE Immunization Evidence

The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.

Authored by: Atkins, K.E., Carroll, S., et al.

Appears in:

Key Concept

Key Evidence: In a UK cost-effectiveness analysis, which takes into account herd effect, the budget impact analysis demonstrated that the introduction of a rotavirus vaccine (RVV) program could pay back between 58-96% of the cost outlay for the program within the first 4 years.

Published In

Atkins, K.E., Carroll, S., et al. 2012. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.. Vaccine. 30(48), 6766.

Disease or Vaccine